RAGZORT Trademark

Trademark Overview

On Thursday, December 7, 2023, a trademark application was filed for RAGZORT with the United States Patent and Trademark Office. The USPTO has given the RAGZORT trademark a serial number of 79388769. The federal status of this trademark filing is REGISTERED as of Tuesday, April 22, 2025. This trademark is owned by Sumitomo Pharma Co., Ltd.. The RAGZORT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the central nervous system; cells for medical use
ragzort

General Information

Serial Number79388769
Word MarkRAGZORT
Filing DateThursday, December 7, 2023
Status700 - REGISTERED
Status DateTuesday, April 22, 2025
Registration Number7764402
Registration DateTuesday, April 22, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the central nervous system; cells for medical use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRACTHERA Co., Ltd.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameSumitomo Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Friday, February 9, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, February 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 16, 2024APPLICATION FILING RECEIPT MAILED
Monday, July 8, 2024ASSIGNED TO EXAMINER
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 6, 2024REFUSAL PROCESSED BY MPU
Tuesday, August 6, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, August 25, 2024REFUSAL PROCESSED BY IB
Monday, October 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 22, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 22, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, July 3, 2025CHANGE OF OWNER RECEIVED FROM IB
Monday, July 7, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, July 7, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 22, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, July 26, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, November 12, 2025GENERIC MADRID TRANSACTION CREATED
Wednesday, November 12, 2025GENERIC MADRID TRANSACTION SENT TO IB
Thursday, December 18, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

ragzort cells medical system nervous preparations central pharmaceutical